HomeFile

File

View Category
Coronary disease

In which patients should we attempt chronic total occlusion rechanneling?

Although chronic total occlusion (CTO) is a common finding, there is little consensus as to when such lesions should...
solaci -
Learn More
Structural heart disease

Lotus Valve performance related to pacemaker implantation in patients after TAVR

Courtesy of Dr. Agustín Vecchia. Paravalvular leak was once considered the greatest disadvantage of TAVR when compared to conventional surgery. Nowadays,...
solaci -
Learn More
Coronary disease

Successful CTO reduces local and remote residual ischemia

Courtesy of Dr. Carlos Fava. The presence of Chronic Total Occlusion (CTO) is about 30%, with an ischemic threshold between...
solaci -
Learn More
Antiplatelet

Post DES Dual Antiplatelet Therapy Still under Debate

The NIPPON trial (Nobori Dual Antiplatelet Therapy as Appropriate Duration) was a randomized study comparing a short dual...
solaci -
Learn More
Acute coronary syndromes

PCI Mortality and Volume in One Center: Associated?

The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend...
solaci -
Learn More
Chronic Ischemic cardiopathy

Glycemic control and risk of repeat revascularization

The association between glycemic control after coronary angioplasty and outcomes of the latter is controversial in many...
solaci -
Learn More
Mitral valve

MitraClip: Should We Intervene Earlier?

Courtesy of Dr. Carlos Fava. Repairing the mitral valve with Mitraclip has become an alternative for high risk or inoperable symptomatic patients,...
solaci -
Learn More
Structural heart disease

Post-dilation in TAVI associated to more stroke and more paravalvular regurgitation

Courtesy of Dr. Carlos Fava. Moderate/severe paravalvular regurgitation (PVR) after TAVR is present in 10%-14% of all cases, according to different...
solaci -
Learn More